PHRT
About
Highlights
Projects
Education
Technology
Research
Clinical
Platform Centers & Hubs
Organization
Contact
Menu
About
Highlights
Projects
Education
Technology
Research
Clinical
Platform Centers & Hubs
Organization
Contact
Search
Search
Close this search box.
Relapsed/refractory AML treatment by Pharmacoscopy-Identified Drugs, a randomized phase-2 clinical trial (PHRT RAPID) – PHRT
Project
Relapsed/refractory AML treatment by Pharmacoscopy-Identified Drugs, a randomized phase-2 clinical trial (PHRT RAPID)
The lay summary for this project is work-in-progress.
Clinical Trial
Prof. Dr. Berend Snijder
ETH Zurich
Co-Investigators
Prof. Dr. med. Markus Manz
PD Dr. med. Alexandre Theocharides
Consortium
Status
In Progress
8th Call
,
Clinical Trial
Funded by